These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20592581)

  • 1. Novel missense mutation in charged multivesicular body protein 2B in a patient with frontotemporal dementia.
    Ferrari R; Kapogiannis D; Huey ED; Grafman J; Hardy J; Momeni P
    Alzheimer Dis Assoc Disord; 2010; 24(4):397-401. PubMed ID: 20592581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal dementia caused by CHMP2B mutations.
    Isaacs AM; Johannsen P; Holm I; Nielsen JE;
    Curr Alzheimer Res; 2011 May; 8(3):246-51. PubMed ID: 21222599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
    Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
    Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review.
    Li C; Wen Y; Zhao M; Wang Y; Li P; Wang L; Wang S
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2222. PubMed ID: 37272767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CHMP2B
    Krasniak CS; Ahmad ST
    Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.
    Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM
    Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3.
    Haukedal H; Syshøj Lorenzen S; Winther Westi E; Corsi GI; Gadekar VP; McQuade A; Davtyan H; Doncheva NT; Schmid B; Chandrasekaran A; Seemann SE; Cirera S; Blurton-Jones M; Meyer M; Gorodkin J; Aldana BI; Freude K
    Brain Behav Immun; 2023 Oct; 113():353-373. PubMed ID: 37543250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHMP2B mutations are rare in French families with frontotemporal lobar degeneration.
    Ghanim M; Guillot-Noel L; Pasquier F; Jornea L; Deramecourt V; Dubois B; Le Ber I; Brice A;
    J Neurol; 2010 Dec; 257(12):2032-6. PubMed ID: 20625756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.
    Roos P; Johannsen P; Lindquist SG; Brown JM; Waldemar G; Duno M; Nielsen TT; Budtz-Jørgensen E; Gydesen S; Holm IE; Collinge J; Isaacs AM; ; Nielsen JE
    Acta Neurol Scand; 2022 May; 145(5):529-540. PubMed ID: 34997757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective activity of ursodeoxycholic acid in CHMP2B
    West RJH; Ugbode C; Fort-Aznar L; Sweeney ST
    Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
    Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
    Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).
    Cox LE; Ferraiuolo L; Goodall EF; Heath PR; Higginbottom A; Mortiboys H; Hollinger HC; Hartley JA; Brockington A; Burness CE; Morrison KE; Wharton SB; Grierson AJ; Ince PG; Kirby J; Shaw PJ
    PLoS One; 2010 Mar; 5(3):e9872. PubMed ID: 20352044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
    Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
    Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Genetics of Frontotemporal Dementia Elucidated by
    Vandal SE; Zheng X; Ahmad ST
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.
    van der Zee J; Urwin H; Engelborghs S; Bruyland M; Vandenberghe R; Dermaut B; De Pooter T; Peeters K; Santens P; De Deyn PP; Fisher EM; Collinge J; Isaacs AM; Van Broeckhoven C
    Hum Mol Genet; 2008 Jan; 17(2):313-22. PubMed ID: 17956895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
    Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM
    Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal dementia: implications for understanding Alzheimer disease.
    Goedert M; Ghetti B; Spillantini MG
    Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a006254. PubMed ID: 22355793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.
    Ugbode C; West RJH
    Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).
    Rostgaard N; Roos P; Budtz-Jørgensen E; Johannsen P; Waldemar G; Nørremølle A; Lindquist SG; Gydesen S; Brown JM; Collinge J; Isaacs AM; ; Nielsen TT; Nielsen JE
    Neurobiol Aging; 2017 Nov; 59():221.e1-221.e7. PubMed ID: 28888721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.